Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

Individualized treatment regimens may reduce patient burden with satisfactory patient outcomes in neovascular age-related macular degeneration. Intravitreal anti-VEGF drugs are the current gold standard. Fixed monthly injections offer the best visual outcome but this regimen is not commonly followed...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Layana, Alfredo, Figueroa, Marta S., Arias, Luis, Araiz, Javier, Ruiz-Moreno, José María, García-Arumí, José, Gómez-Ulla, Francisco, López-Gálvez, María Isabel, Cabrera-López, Francisco, García-Campos, José Manuel, Monés, Jordi, Cervera, Enrique, Armadá, Felix, Gallego-Pinazo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600506/
https://www.ncbi.nlm.nih.gov/pubmed/26491550
http://dx.doi.org/10.1155/2015/412903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600506/
https://www.ncbi.nlm.nih.gov/pubmed/26491550
http://dx.doi.org/10.1155/2015/412903

Ejemplares similares